Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...
Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
The AIDS Society of India (ASI) on Friday urged the government to include HIV self-testing and pre-exposure prophylaxis (PrEP) medicine, taken to prevent from HIV, in its policies and programmes ...
The venereal disease has increased more in recent years among women, including those who are pregnant. Six babies with congenital syphilis last year died.